RNTX
Rein Therapeutics
RNTX
RNTX
37 hedge funds and large institutions have $8.34M invested in Rein Therapeutics in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
49% less capital invested
Capital invested by funds: $16.5M → $8.34M (-$8.16M)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Holders
37
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$36.9K | |
| 2 | +$20K | |
| 3 | +$14.8K | |
| 4 |
Jane Street
New York
|
+$10.8K |
| 5 |
State Street
Boston,
Massachusetts
|
+$8.17K |
Top Sellers
| 1 | -$66K | |
| 2 | -$51K | |
| 3 | -$50.1K | |
| 4 |
Citigroup
New York
|
-$15K |
| 5 |
KWM
Keebeck Wealth Management
Chicago,
Illinois
|
-$14K |